SUNY Upstate Medical was recently congratulated by New York’s Gov. Andrew W. Cuomo for developing what is positioned as the number one ranking COVID-19 saliva test by the U.S. Food and Drug Administration (FDA) for detecting the virus in its earliest stages. This test, known as Clarifi COVID-19, was developed by Upstate Medical and a start-up Quadrant Biosciences. Identified by the FDA as one of the most sensitive COVID-19 tests, regardless of type, it now ranks 6th worldwide in detecting the virus, according to Upstate Medical’s news release. Economical and easy to use, the virus test has purportedly aided the New York university system in identifying cases at the earliest stages of the virus.
TrialSite offers a brief breakdown concerning this SUNY Upstate COVID-19 test.
What class of test does the Clarifi COVID-19 test fall under?
The saliva test
What has the FDA’s review of this test revealed about Clarifi COVID-19 test?
The FDA found that this test has the best (lowest) limit of detection (LoD)at 600 copies of the virus per milliliter. According to the recent Upstate Medical news, the FDA’s recent published results reveal this particular test is the highest...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).